SHARE

EIT Health-supported SpotLab celebrates market launch

17th March 2023

Spanish start-up, SpotLab, has launched an intelligent fully integrated mobile platform for remote analysis of medical images to the market. They are also celebrating their first sales to pharmaceutical companies and global health institutions. 

Founded by María Postigo Camps, who attended EIT Health’s Women Entrepreneurship Bootcamp in 2021, Spotlab is a social enterprise that creates artificial intelligence with clinical impact. The healthtech start-up is a spin-off from Universidad Politécnica de Madrid. 

SpotLab’s innovative solution for biomedical research and diagnostics transforms smartphones into medical devices. It uses 3D printing to acquire images that are analysed through artificial intelligence (AI). Their aim is to achieve universal healthcare for all by bringing AI to diseases that are not yet in the digital world. 

SpotLab’s Founder, María, found EIT Health’s Women Entrepreneurship Bootcamp incredibly helpful to develop the company’s business plan and present it to investors. María’s mentor helped her present the start-up’s innovations, value proposition, and market fit in a clear and compelling manner.  

“It’s been an exceptional Bootcamp. With key lessons to deepen our understanding of the health sector, and to empower our tools as entrepreneurs. An occasion to expand personal and professional networks at the international level. With brilliant entrepreneurs, and relevant mentors and stakeholders within the health-tech sector,” said María. 

Applications for our next Women Entrepreneurship Bootcamp close 20 March 2023. Learn more and apply now.  

EIT Health-supported Vitadio earns permanent DiGA status

EIT Health-supported Vitadio earns permanent DiGA status

Learn how we helped them grow.

Find out more

Skill Sync: Bridging Europe's AI skills gap

Skill Sync: Bridging Europe's AI skills gap

Learn how we're addressing the AI skills gap.

Find out more

EIT Health-supported start-up Ochre Bio signs $1BN+ deal with Boehringer Ingelheim

EIT Health-supported start-up Ochre Bio signs $1BN+ deal with Boehringer Ingelheim

Learn how we supported their journey.

Find out more